Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Featured Article
Artificial Intelligence (AI) continues to gain momentum in the pharmaceutical sector, but can it truly deliver...
Source: Health Tech World
- Featured Article
Dr Laura Trotta gives us an insight into her role at CluePoints and shares some of...
Source: Health Tech World
- Featured Article
Sas Maheswaran discusses how artificial intelligence, data and strategic partnerships can make clinical trials more sustainable...
Source: ONdrugDelivery
- Featured Article
Andrew Cooper, CEO, CluePoints, explores how AI is transforming clinical trials, the power of a purpose-driven...
Source: European Medical Journal GOLD
- Press Release
RBQM and AI leader was shortlisted for its Time Similarity Test in the ‘Innovative Clinical Trial...
- Featured Article
The monitoring of key risk indicators (KRIs) is an established form of risk control in the...
Source: Applied Clinical Trials
- Press Release
King of Prussia, PA – April 1st, 2025: CluePoints, provider of leading statistical and AI-driven software...
- Featured Article
Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM)...
Source: The Clinical Trial Vanguard
- Press Release
The Company, along with its Research and Development Teams, were shortlisted for continuing its mission of...
- Featured Article
The pharmaceutical industry is poised for a transformative evolution by 2025, driven by the possibilities of...
Source: PM360
- Featured Article
Central monitoring is highly effective in detecting emerging quality issues in clinical trials, but debate continues...
Source: Applied Clinical Trials
- Featured Article
An essential component of risk-based quality management (RBQM), as detailed in both the ICH E8 (R1)...
Source: Applied Clinical Trials
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has...
- Press Release
We’re thrilled to announce that CluePoints’ latest version (1.9.0) of the Central Monitoring platform is live!...
- Press Release
The ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop is fast approaching and we’re thrilled to announce that...
- Press Release
Today, we’re thrilled to unveil CluePoints’ latest release of its award-winning Risk-Based Monitoring Software. For this...
- Press Release
Join CluePoints CEO Francois Torche and OmniComm Sr. Director Steve Young at this special thought leadership...
- Press Release
Awards recognize CluePoints’ Risk-Based Monitoring solution in the ‘Best Sponsor-Focused Technological Development’ category. Cambridge, MA –...
- Press Release
Partnership will combine CluePoints’ Risk-Based Monitoring Software with Widler & Schiemann’s Consultancy Services Cambridge, MA –...
- Press Release
Cambridge, MA – CluePoints, a leading software provider of risk-based monitoring (RBM) solutions for clinical trials,...
- Press Release
Cambridge, MA – CluePoints, a leading software provider of risk-based monitoring (RBM) solutions for clinical trials,...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials,...
- Press Release
Cambridge, MA – CluePoints, a leading software provider of risk-based monitoring (RBM) solutions for clinical trials,...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials,...
- Featured Article
Returning to the series is CluePoints, with Sophie Henderson, senior strategic consultant, sharing her hopes and...
Source: Discover Pharma
- Featured Article
Regulatory changes, including the launch of ICH E6(R3) and Good Clinical Practice (GCP) updates, have highlighted...
Source: International Pharmaceutical Industry
- Featured Article
Sophie Henderson, Senior Strategic Consultant at CluePoints, said: “This year we have seen risk-based quality management...
Source: Discover Pharma
- Featured Article
As clinical trials become more complex, leading sponsors are shifting the focus of their clinical research...
Source: The Association of Clinical Research Professionals
- Featured Article
Source: Applied Clinical Trials
- Featured Article
Ken McFarlane of CluePoints shares insight on better, smarter ways to detect risk, streamline data review,...
Source: Contract Pharma
- Featured Article
As a follow-up to Clinical Trials Day 2025, held on May 20 with the theme of...
Source: The Association of Clinical Research Professionals
- Featured Article
“Identifying … potential data manipulation and data integrity problems” are an International Council for Harmonization of...
Source: Applied Clinical Trials
- Featured Article
Artificial Intelligence (AI) continues to gain momentum in the pharmaceutical sector, but can it truly deliver...
Source: Health Tech World
- Featured Article
Dr Laura Trotta gives us an insight into her role at CluePoints and shares some of...
Source: Health Tech World
- Featured Article
Sas Maheswaran discusses how artificial intelligence, data and strategic partnerships can make clinical trials more sustainable...
Source: ONdrugDelivery
- Featured Article
Andrew Cooper, CEO, CluePoints, explores how AI is transforming clinical trials, the power of a purpose-driven...
Source: European Medical Journal GOLD
